Fulgent Genetics (FLGT) Other Non-Current Liabilities (2016 - 2026)

Fulgent Genetics has disclosed Other Non-Current Liabilities across 10 years of filings, most recently posting $9.4 million for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $9.4 million, up 53.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.4 million (up 53.09% YoY), and the FY2025 annual result was $7.6 million, up 2017.78% from the prior year.
• Other Non-Current Liabilities came in at $9.4 million for Q1 2026 at Fulgent Genetics, up from $7.6 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $20.0 million in Q3 2022 to a low of $182000.0 in Q2 2025.
• The 5-year median for Other Non-Current Liabilities is $6.3 million (2024), against an average of $8.3 million.
• Across the five-year window, Other Non-Current Liabilities surged 2415.17% in 2022 and plunged 96.17% in 2025, its largest moves.
• Fulgent Genetics' Other Non-Current Liabilities stood at $18.2 million in 2022, then slumped by 67.22% to $6.0 million in 2023, then sank by 93.98% to $360000.0 in 2024, then surged by 2017.78% to $7.6 million in 2025, then gained by 22.93% to $9.4 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $9.4 million (Q1 2026), $7.6 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.